Emerging Drug Delivery Vectors: Engineering of Plant-Derived Nanovesicles and Their Applications in Biomedicine
Lu-Yao Yang,Chao-Qing Li,Yu-Lin Zhang,Meng-Wen Ma,Wan Cheng,Guo-Jun Zhang
DOI: https://doi.org/10.2147/ijn.s454794
IF: 7.033
2024-03-14
International Journal of Nanomedicine
Abstract:Lu-Yao Yang, 1, &ast Chao-Qing Li, 1, 2, &ast Yu-Lin Zhang, 1, 2 Meng-Wen Ma, 3 Wan Cheng, 3 Guo-Jun Zhang 1, 2 1 School of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, 430065, People's Republic of China; 2 Hubei Shizhen Laboratory, Wuhan, 430065, People's Republic of China; 3 Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics - Hubei Bioinformatics & Molecular Imaging Key Laboratory, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, People's Republic of China &astThese authors contributed equally to this work Correspondence: Guo-Jun Zhang, School of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, People's Republic of China, Email Extracellular vesicles can transmit intercellular information and transport biomolecules to recipient cells during various pathophysiological processes in the organism. Animal cell exosomes have been identified as potential nanodrugs delivery vehicles, yet they have some shortcomings such as high immunogenicity, high cytotoxicity, and complicated preparation procedures. In addition to exosomes, plant-derived extracellular vesicles (PDVs), which carry a variety of active substances, are another promising nano-transport vehicles emerging in recent years due to their stable physicochemical properties, wide source, and low cost. This work briefly introduces the collection and characterization of PDVs, then focuses on the application of PDVs as natural or engineered drug carriers in biomedicine, and finally discusses the development and challenges of PDVs in future applications. Keywords: plant-derived vesicles, activated biomaterials, nanodrugs delivery systems, biomedicine applications Biofilms have subdivided the intracellular space into different regions so that various biochemical reactions can be carried out independently in different spaces, thus enabling the synergistic and functionalization of cellular activities. In addition to the intracellular membrane system, extracellular membrane structures called extracellular vesicles (EVs) also exist outside the cell, which usually include exosomes, microvesicles, and apoptotic vesicles, and their diameters are usually in the range of 40–1000 nm. 1 In mammalian cells, the most representative EVs are exosomes, which were first discovered in 1983. 2 Studies have shown that almost all living cells could secrete exosomes, including animals, plants, and microorganisms. 1 EVs could mediate signal transduction and material transfer between donor and recipient cells directly through a variety of mechanisms including fusion with the recipient cell membrane, receptor-ligand interactions, lattice-mediated cytokinesis, and receptor-mediated cytokinesis to alter the behavior of target cells. It plays an important role in cellular communication such as cell proliferation, tumor angiogenesis, inflammation, and cancer development. 3 EVs also have excellent physicochemical properties, such as high stability, low immunogenicity, and long circulation time, and they can carry bioactive molecules such as nucleic acids and proteins for trans-spatial transfer. So EVs are prepared in large quantities for drug molecule delivery carriers. 4 Wood was the first to inject siRNA-carrying EVs intravenously into mice, and the EVs were able to reach the mouse brain and exert therapeutic effects. 5 Zhuang et al used EVs loaded with anti-inflammatory drugs and successfully crossed the blood-brain barrier after intranasal administration. 6 Even though plant-derived vesicles predated the discovery of animal cell exosomes by about 15 years, research on PDVs has been less successful. Researchers are once skeptical that plant cells could produce EVs because of the vast structural differences between plant and animal cells, such as the fact that plant cells have cell walls. As early as 1967, Halperin et al observed by transmission electron microscopy that multivesicular structures arising in carrot cells were able to fuse with the plasma membrane and subsequently release secondary vesicles containing contents into the extracellular space. 7 Subsequently, an increasing number of studies have focused on these plant-derived nanovesicles. Table 1 shows the comparison of plant-derived vesicles with animal-derived exosomes. Regente et al obtained extracellular fluid from sunflower seeds and detected the presence of phospholipid components. In the following year, Laura de la canal et al first isolated EVs from sunflower seeds by vacuum permeation-centrifugation. -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology